Regencell Bioscience Holdings Stock Market Value
| RGC Stock | USD 31.22 2.20 7.58% |
| Symbol | Regencell |
Will Biotechnology sector continue expanding? Could Regencell diversify its offerings? Factors like these will boost the valuation of Regencell Bioscience. Anticipated expansion of Regencell directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Regencell Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Investors evaluate Regencell Bioscience using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Regencell Bioscience's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Regencell Bioscience's market price to deviate significantly from intrinsic value.
It's important to distinguish between Regencell Bioscience's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Regencell Bioscience should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Regencell Bioscience's market price signifies the transaction level at which participants voluntarily complete trades.
Regencell Bioscience 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regencell Bioscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regencell Bioscience.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Regencell Bioscience on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Regencell Bioscience Holdings or generate 0.0% return on investment in Regencell Bioscience over 90 days. Regencell Bioscience is related to or competes with Cytokinetics, AptarGroup, Grifols SA, Abivax SA, Rhythm Pharmaceuticals, Stevanato Group, and Axsome Therapeutics. Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine bioscience company More
Regencell Bioscience Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regencell Bioscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regencell Bioscience Holdings upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.33 | |||
| Information Ratio | 0.1469 | |||
| Maximum Drawdown | 86.33 | |||
| Value At Risk | (13.98) | |||
| Potential Upside | 22.98 |
Regencell Bioscience Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regencell Bioscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regencell Bioscience's standard deviation. In reality, there are many statistical measures that can use Regencell Bioscience historical prices to predict the future Regencell Bioscience's volatility.| Risk Adjusted Performance | 0.1322 | |||
| Jensen Alpha | 1.87 | |||
| Total Risk Alpha | 1.01 | |||
| Sortino Ratio | 0.2054 | |||
| Treynor Ratio | 1.1 |
Regencell Bioscience February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1322 | |||
| Market Risk Adjusted Performance | 1.11 | |||
| Mean Deviation | 8.53 | |||
| Semi Deviation | 8.18 | |||
| Downside Deviation | 9.33 | |||
| Coefficient Of Variation | 656.88 | |||
| Standard Deviation | 13.05 | |||
| Variance | 170.26 | |||
| Information Ratio | 0.1469 | |||
| Jensen Alpha | 1.87 | |||
| Total Risk Alpha | 1.01 | |||
| Sortino Ratio | 0.2054 | |||
| Treynor Ratio | 1.1 | |||
| Maximum Drawdown | 86.33 | |||
| Value At Risk | (13.98) | |||
| Potential Upside | 22.98 | |||
| Downside Variance | 87.09 | |||
| Semi Variance | 66.94 | |||
| Expected Short fall | (10.06) | |||
| Skewness | 1.73 | |||
| Kurtosis | 6.23 |
Regencell Bioscience Backtested Returns
Regencell Bioscience is slightly risky given 3 months investment horizon. Regencell Bioscience maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.21% are justified by taking the suggested risk. Use Regencell Bioscience Semi Deviation of 8.18, coefficient of variation of 656.88, and Risk Adjusted Performance of 0.1322 to evaluate company specific risk that cannot be diversified away. Regencell Bioscience holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of 1.79, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regencell Bioscience will likely underperform. Use Regencell Bioscience jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Regencell Bioscience.
Auto-correlation | -0.4 |
Poor reverse predictability
Regencell Bioscience Holdings has poor reverse predictability. Overlapping area represents the amount of predictability between Regencell Bioscience time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regencell Bioscience price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Regencell Bioscience price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.37 | |
| Residual Average | 0.0 | |
| Price Variance | 46.46 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Regencell Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regencell Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regencell Bioscience Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regencell Bioscience Holdings Stock:Check out Regencell Bioscience Correlation, Regencell Bioscience Volatility and Regencell Bioscience Performance module to complement your research on Regencell Bioscience. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Regencell Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.